Journal of Interventional Cardiology logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 19, Number 5, October 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Effect of Postconditioning on Coronary Blood Flow Velocity and Endothelial Function and LV Recovery After Myocardial Infarction
pp. 367-375(9)
Authors: MA, XIAOJING; ZHANG, XINGHUA; LI, CHUNMEI; LUO, MAN

Predictors of Recurrent In-Stent Restenosis after Beta-Radiation: An Analysis from the START 40/20 Trial
pp. 376-380(5)
Authors: KANEDA, HIDEAKI; HONDA, YASUHIRO; MORINO, YOSHIHIRO; LANSKY, ALEXANDRA J.; YOCK, PAUL G.; BONAN, RAOUL; FITZGERALD, PETER J.

Age-Based Differences of Percutaneous Coronary Intervention in the Drug-Eluting Stent Era
pp. 381-387(7)
Authors: FLOYD, KEVIN C.; JAYNE, JOHN E.; KAPLAN, AARON V.; FRIEDMAN, BRUCE J.; NILES, NATHANIEL W.; HETTLEMAN, BRUCE D.; ROBB, JOHN F.; THOMPSON, CRAIG A.

The Relationship of Body Mass Index to Outcomes after Percutaneous Coronary Intervention
pp. 388-395(8)
Authors: SHUBAIR, MAMDOUH M.; PRABHAKARAN, POORNIMA; PAVLOVA, VIKTORIA; VELIANOU, JAMES L.; SHARMA, ARYA M.; NATARAJAN, MADHU K.

Proceedings of TCT: Current Status of Catheter-Based Mitral Valve Repair Therapies
pp. 396-400(5)
Author: FELDMAN, TED

Coronary Venous Capture of Contrast during Angiography
pp. 401-404(4)
Authors: MEYER, MARKUS; DAUERMAN, HAROLD L.; BELL, STEPHEN P.; LEWINTER, MARTIN M.; LUSTGARTEN, DANIEL L.

Overview of Pharmacology and Clinical Trials Program with the Zotarolimus-Eluting Endeavor Stent
pp. 405-413(9)
Authors: KANDZARI, DAVID E.; LEON, MARTIN B.

Update on Bioabsorbable Stents: From Bench to Clinical
pp. 414-421(8)
Author: WAKSMAN, RON

An Overview of the TAXUS® Express®, Paclitaxel-Eluting Stent Clinical Trial Program
pp. 422-431(10)
Authors: LASALA, JOHN M.; STONE, GREGG W.; DAWKINS, KEITH D.; SERRUYS, PATRICK W.; COLOMBO, ANTONIO; GRUBE, EBERHARD; KOGLIN, JOERG; ELLIS, STEPHEN

Off-Label Use: An Industry Perspective on Expanding Use Beyond Approved Indications
pp. 432-438(7)
Authors: RUSSELL, MARY E.; FRIEDMAN, MARK I.; MASCIOLI, STEPHEN R.; STOLZ, LESLIE E.

Aspirin and Clopidogrel Resistance: Consideration and Management
pp. 439-448(10)
Authors: GURBEL, PAUL A.; TANTRY, UDAYA S.

The Evolving Role of Glycoprotein IIb/IIIa Inhibitor Therapy in Contemporary Care of Acute Coronary Syndrome Patients
pp. 449-455(7)
Authors: TRICOCI, PIERLUIGI; PETERSON, ERIC D.

Debate of Adjunctive Pharmacology for Percutaneous Coronary Intervention: Anticoagulation and Clopidogrel Are Not (Always) Enough
pp. 456-463(8)
Author: TCHENG, JAMES E.

Debate of Adjunctive Pharmacology for Percutaneous Coronary Intervention: Thrombin Inhibitors and Clopidogrel Are Enough
pp. 464-469(6)
Authors: YEHUDAI, LORAN; FEIT, FREDERICK

Cardiac Catheterization in Congenital Heart Disease: Pediatric and Adult By Charles E. Mullins
pp. 470-471(2)

FDA Happenings/Around the Industry
pp. 472-474(3)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A